首页> 外文期刊>Advanced Powder Technology: The internation Journal of the Society of Powder Technology, Japan >A study of the impact of polymer-surfactant in drug nanoparticle coated pharmatose composites on dissolution performance
【24h】

A study of the impact of polymer-surfactant in drug nanoparticle coated pharmatose composites on dissolution performance

机译:药物表面活性剂在药物纳米颗粒包覆的复合药物中对溶出性能的影响研究

获取原文
获取原文并翻译 | 示例
       

摘要

Without a proper stabilizer formulation, drug nanoparticles can aggregate during the formation of nanosuspensions and their drying into composite powders, which in turn can cause inadequate bioavailability enhancement from nanoparticles and ensuing lack of therapeutic efficacy. In this study, formulations with various polymer concentrations-molecular weights in the presence/absence of a surfactant were explored to assess their impact on redispersibility and drug dissolution from the composites. Suspensions of griseofulvin (GF), a poorly water-soluble drug, were prepared by wet stirred media milling and subsequently dried via fluidized bed drying-coating onto Pharmatose (R) carrier particles. Hydroxypropyl cellulose (HPC), with various molecular weights, sodium dodecyl sulfate (SDS), and their combinations were used as stabilizers during the milling. The dried composites were redispersed in water and SDS solution to recover the GF nanoparticles. Particle sizing via laser diffraction, SEM imaging, and dissolution testing were performed to investigate the redispersion and dissolution performance. Results show that good physical stability of the milled suspension is necessary, but not sufficient to guarantee fast redispersion-drug dissolution. For best performance, presence of SDS is critical; a minimum concentration of the polymer, as a film former, is also required to prevent the formation of hard aggregates during drying. (C) 2016 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.
机译:如果没有合适的稳定剂配方,则药物纳米颗粒会在纳米悬浮液的形成过程中聚集并干燥成复合粉末,从而导致纳米颗粒的生物利用度不足,从而导致治疗效果不足。在这项研究中,探索了在存在/不存在表面活性剂的情况下具有各种聚合物浓度-分子量的制剂,以评估其对复合物的再分散性和药物溶解的影响。灰黄霉素(GF)(一种水溶性差的药物)的悬浮液是通过湿式搅拌介质研磨制备的,然后通过流化床干燥将其包衣在Pharmatose(R)载体颗粒上进行干燥。具有不同分子量的羟丙基纤维素(HPC),十二烷基硫酸钠(SDS)及其组合在研磨过程中用作稳定剂。将干燥的复合材料重新分散在水和SDS溶液中,以回收GF纳米颗粒。通过激光衍射,SEM成像和溶出度测试进行粒度分析,以研究其再分散和溶出性能。结果表明,研磨过的悬浮液具有良好的物理稳定性是必要的,但不足以保证快速的再分散-药物溶解。为了获得最佳性能,SDS的存在至关重要。作为成膜剂,还需要聚合物的最小浓度以防止干燥期间形成硬聚集体。 (C)2016日本粉末技术学会。由Elsevier B.V.和日本粉末技术学会出版。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号